BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  GBT Appoints Wendy L. Yarno to Board of Directors

  Ms. Yarno has more than 25 years of experience in the biopharmaceutical industry, including serving as chief marketing officer at Merck.

  December 22, 2017

   · 

  6 min read
• Business

  Roche and Accenture Collaborate to Enhance Digital Healthcare for Cancer Patients

  Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.

  December 22, 2017

   · 

  2 min read
• BioMidwest

  SAB Biotherapeutics Launches Utah-Based Subsidiary SAB Capra, LLC.

  SAb Biotherapeutics announced today they have formed and officially launched a Utah-based wholly owned subsidiary, SAB Capra, LLC and incorporated the new entity under the SAB Biotherapeutics corporate umbrella.

  December 22, 2017

   · 

  4 min read
• Business

  THERADIAG Signs a Partnership Agreement for Monitoring of Remicade

  Theradiag today announced that it had signed a partnership with MSD France to supply its LISA TRACKER kits for the monitoring of Remicade.

  December 22, 2017

   · 

  2 min read
• Biotech Bay

  Frost & Sullivan Projects CRISPR Technology Will be Fastest Growing Gene Editing Market Segment

  Frost & Sullivan expects that multiple applications of CRISPR genome editing technology can generate almost $25B in revenue by 2030s.

  December 22, 2017

   · 

  3 min read
• BioCapital

  Metavivor Announces 2017 Grant Awards for Metastatic Cancer Research

  METAvivor Research and Support, a non-profit organization dedicated to funding research for Stage IV MBC, announces twelve grant awards totaling $1,650,000.

  December 22, 2017

   · 

  4 min read
• Pharm Country

  John Theurer Cancer Center Release: Pivotal CAR-T Therapy Cancer Study Published in the New England Journal of Medicine

  John Theurer Cancer Center at Hackensack University Medical Center is the only New Jersey center that participated in a pivotal clinical trial of a groundbreaking cancer treatment, CAR-T Cell therapy, which genetically modifies a patient’s immune system to attack cancer cells.

  December 22, 2017

   · 

  5 min read
• Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

  Orchard Therapeutics today announced that Mark Rothera, president and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2018 at 3:00 p.m. PT.

  December 22, 2017

   · 

  1 min read
• Drug Development

  Glycotope Initiates Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies

  Glycotope today announces it has enrolled the first patient in its international GATTO study which combines two of the Company’s immuno-oncology assets derived from its world-leading glycobiology expertise.

  December 22, 2017

   · 

  4 min read
• Pharm Country

  Akers Bio Announces Closing of $6,900,000 Public Offering

  The funds raised will be used for working capital, product development, marketing activities, expanding our internal sales organization and further developing sales channels and other capital expenditures.

  December 22, 2017

   · 

  4 min read